Your browser doesn't support javascript.
loading
Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
Zimmerman, Y; Foidart, J-M; Pintiaux, A; Minon, J-M; Fauser, B C J M; Cobey, K; Coelingh Bennink, H J T.
Afiliación
  • Zimmerman Y; Pantarhei Bioscience, Zeist, the Netherlands. Electronic address: yz@pantarheibio.com.
  • Foidart JM; Department of Gynecology-Obstetrics, University Hospital CHR Citadelle, Site Sainte Rosalie in Liège, Liège, Belgium.
  • Pintiaux A; Department of Gynecology-Obstetrics, University Hospital CHR Citadelle, Site Sainte Rosalie in Liège, Liège, Belgium.
  • Minon JM; Department of Laboratory Medicine, University Hospital CHR Citadelle, Liège, Belgium.
  • Fauser BC; Department of Reproductive Medicine & Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Cobey K; Department of Psychology, School of Natural Sciences, University of Stirling, Stirling, United Kingdom.
  • Coelingh Bennink HJ; Pantarhei Bioscience, Zeist, the Netherlands.
Contraception ; 91(2): 127-33, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25604900
OBJECTIVES: Combined oral contraceptives (COCs) decrease testosterone (T) levels. This study investigated restoration of T and other androgen concentrations during COC use by 'co-administration' of dehydroepiandrosterone (DHEA). STUDY DESIGN: In this randomized, double-blind, placebo-controlled study in 99 new COC starters (18-35 years old with body mass index range 18-34 kg/m²), a COC containing 30mcg ethinylestradiol (EE) and 3 mg drospirenone (DRSP) was used for 3cycles, followed by 6cycles of the same COC combined with either 50 mg/day DHEA or placebo. Total T, albumin, sex hormone-binding globulin (SHBG), DHEA-sulfate (DHEA-S), Δ4-androstenedione (AD), 3α-androstanediol glucuronide (ADG) and estradiol (E2) were measured, whereas free T and the free T index (FTI) were calculated. Assessments took place at baseline (no COC use), after the run-in period (COC use alone) and during the treatment period (DHEA or placebo). RESULTS: During COC use alone, androgen levels decreased, especially total T by 62% and free T by 86%, and SHBG increased by 243%. Total T increased with DHEA compared to placebo (change from end of run-in period to end of treatment period -- 1.3±1.2 nmol/L vs. 0.0±0.4 nmol/L; p<.0001) -- and was restored to baseline levels. Free T and the FTI increased significantly (p<.0001), but the free T level was still 53% below baseline levels. DHEA-S, AD and ADG increased significantly to levels above baseline (p<.0001 for each). DHEA had no effect on SHBG, albumin and E2. CONCLUSIONS: An EE/DRSP containing COC strongly suppressed endogenous androgen concentrations in all users. The addition of 50 mg DHEA to a COC regimen containing EE/DRSP restored total T to baseline levels, but free T levels were restored by only 47% as most of the T remains bound to SHBG. IMPLICATIONS: When using a COC that increases SHBG considerably, a daily dose of 50 mg DHEA is insufficient to normalize free T levels completely.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Testosterona / Globulina de Unión a Hormona Sexual / Regulación hacia Arriba / Deshidroepiandrosterona / Anticonceptivos Orales Combinados / Etinilestradiol / Hipogonadismo / Androstenos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Contraception Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Testosterona / Globulina de Unión a Hormona Sexual / Regulación hacia Arriba / Deshidroepiandrosterona / Anticonceptivos Orales Combinados / Etinilestradiol / Hipogonadismo / Androstenos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Contraception Año: 2015 Tipo del documento: Article
...